LCM
NMTC icon

Legato Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Legato Capital Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2K Sell
10,273
-1
-0% -$4 ﹤0.01% 673
2026
Q1 		$47.9K Buy
10,274
+2,886
+39% +$13.9K ﹤0.01% 714
2025
Q4 		$33.6K Buy
+7,388
New +$33.6K ﹤0.01% 745

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Legato Capital Management's NMTC Position: Q2 2026 in Review

Legato Capital Management reduced its NeuroOne Medical Technologies (NMTC) stake by 0.01% in Q2 2026, selling an estimated $4 and leaving 10,273 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Legato Capital Management first reported a position in NMTC in Q4 2025 and has held it in 3 quarters since. The position peaked at $47.9K in Q1 2026. 26 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Legato Capital Management held 10,273 shares of NeuroOne Medical Technologies worth $31.2K as of Q2 2026.
  • Legato Capital Management sold 1 NeuroOne Medical Technologies share in Q2 2026, an estimated $4.
  • NeuroOne Medical Technologies made up ﹤0.01% of Legato Capital Management's portfolio in Q2 2026, its #673 holding.
  • Legato Capital Management first reported a position in NeuroOne Medical Technologies in Q4 2025 and has held it in 3 quarters since.
  • Legato Capital Management's NeuroOne Medical Technologies position peaked at $47.9K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.